U.S. Residential REITs Stock News

If you are wondering whether Biogen's current share price offers good value or if you might be paying too much for its future potential, this article walks through what the numbers are actually saying. Biogen shares closed at US$176.18, with returns of 2.7% over the last 7 days, 0.1% over 30 days, a 0.9% decline year to date, a 22.4% return over 1 year, a 37.9% decline over 3 years and a 33.5% decline over 5 years. This gives a mixed picture for investors weighing recent momentum against...

If you are wondering whether First Horizon's current share price lines up with its underlying worth, you are not alone, and that is exactly what this article will unpack. The stock most recently closed at US$24.42, with returns of 1.2% year to date and 14.5% over the last year. Over the past 5 years it shows a 91.2% return, with a 7 day move of a 0.9% decline and a 30 day return of 2.1%. Recent coverage around First Horizon has focused on its position within the US regional banking sector...

If you are wondering whether Tenet Healthcare's current share price still offers value, this article walks through what the numbers say and how to think about the stock in practical terms. Tenet Healthcare recently closed at US$189.49, with a flat 7 day return, a 5.9% decline over 30 days, a 5.0% decline year to date, and longer term returns of 32.3% over 1 year, 227.5% over 3 years and 280.0% over 5 years. Recent coverage of Tenet Healthcare has focused on its position as a large US...

Concentra Group Holdings Parent (CON) has drawn attention after reporting preliminary Q4 and full year 2025 results that exceeded its earlier guidance, along with fresh 2026 outlook figures and updated investor materials. See our latest analysis for Concentra Group Holdings Parent. The latest guidance and buyback update come after a period where the 30 day share price return of 8.22% and year to date share price return of 11.28% contrast with a 1 year total shareholder return decline of...

Carpenter Technology (CRS) opened Q2 2026 with total revenue of US$728 million, basic EPS of US$2.10 and net income excluding extra items of US$105.3 million. This put fresh numbers on a year in which trailing twelve month EPS reached US$8.67 on revenue of US$2.9 billion and net income of US$434.7 million. Over the past year, the company has seen quarterly revenue move from US$676.9 million in Q2 2025 to US$728 million in Q2 2026, while basic EPS stepped up from US$1.67 to US$2.10 and...

CSG Systems International (NasdaqGS:CSGS) has extended its multi year contract with DISH Network to provide billing and payment platform services. The agreement continues a decades long relationship and is set to run through 2030. The renewal supports DISH Network’s customer experience goals while keeping CSG at the core of its connectivity operations. For investors watching NasdaqGS:CSGS, this long term renewal with a major client comes as the stock trades at $79.65, with a 1 year return...

Perspective Therapeutics recently reported updated interim data from its ongoing Phase 1/2a trial of lead radiopharmaceutical candidate VMT-α-NET, indicating sustained anti-tumor activity, and issued a business update outlining clinical priorities and manufacturing expansion plans. This combination of early clinical signals and investment in production capacity highlights how the company is positioning VMT-α-NET as a core asset in its radiopharmaceutical pipeline. We’ll now examine how the...

Why Neogen (NEOG) is on investors’ radar today Neogen (NEOG) has captured attention after a sharp move in its share price over the past month, with recent performance prompting investors to reassess how the company’s food and animal safety business is currently valued. See our latest analysis for Neogen. That sharp 30 day share price return of 44.82% and 90 day gain of 65.48% contrast with a weaker picture over longer horizons, where the 1 year total shareholder return is a decline of 11.06%...

NewAmsterdam Pharma (NAMS) is back in focus after management reported positive Phase 3 data for its lead drug obicetrapib in cardiovascular and Alzheimer’s disease indications and highlighted an upcoming European regulatory decision. See our latest analysis for NewAmsterdam Pharma. Despite the recent positive clinical headlines, NewAmsterdam Pharma’s 7 day share price return of 9.68% and 90 day share price return of 17.15% point to cooling momentum, while its 1 year total shareholder return...

Event-driven snapshot PennyMac Mortgage Investment Trust (PMT) has recently drawn investor attention after its US$13.51 last close, with returns over the past month and past 3 months inviting a closer look at this mortgage-focused REIT. See our latest analysis for PennyMac Mortgage Investment Trust. Looking beyond the recent move to US$13.51, the 30 day share price return of 7.48% and 90 day share price return of 12.21%, alongside a 1 year total shareholder return of 19.06%, point to momentum...

Global-E Online (GLBE) is back in focus after management moved closer to GAAP profitability, highlighted expanding free cash flow, and approved a US$200 million share repurchase program, while flagging fresh tariff and customs related risks. See our latest analysis for Global-E Online. The latest earnings update and buyback news arrive after a tougher stretch for investors, with a 1-year total shareholder return showing a 39.28% decline and a 3-year total shareholder return showing a 12.46%...

Independent Bank Corporation ( NASDAQ:IBCP ) stock is about to trade ex-dividend in three days. Typically, the...

Hyatt Hotels Corporation recently reported a record development pipeline of about 148,000 rooms at year-end 2025 and disclosed a new class action lawsuit in California alleging multiple labor code violations. The company also appointed industry veteran Maria Zarraluqui to a newly created senior role to accelerate growth in its all-inclusive resort collection, signaling a continued focus on expanding this portfolio. We will now examine how Hyatt’s record room pipeline and emphasis on...

Aflac Incorporated ( NYSE:AFL ) has announced that it will be increasing its dividend from last year's comparable...

One Stop Systems, Inc. recently announced a past initial order worth US$1,100,000 from a top-tier aerospace prime contractor to deliver 200 ADB-10G ruggedized Ethernet switches for next-generation in-flight entertainment systems, scheduled for delivery by the fourth quarter of 2026. The company also indicated that this secure, Linux-based platform for in-flight entertainment management and redundancy could generate more than US$6.50 million in revenue over five years, underscoring the...

Event overview Gemini Space Station (GEMI) shares have come under pressure recently, with the stock showing negative returns over the past month and past 3 months, drawing investor attention to its crypto focused business model and fundamentals. See our latest analysis for Gemini Space Station. At a share price of $8.27, Gemini Space Station’s recent moves include a 1 day share price return of 9.38% decline and a 90 day share price return of 54.96% decline, suggesting momentum has been fading...

If you are wondering whether Silgan Holdings at around US$42.71 is offering good value today, you are not alone. The stock’s current price invites a closer look at what you are actually paying for. The share price is up 5.1% over the last 30 days, even though the 1 year return sits at a 22.6% decline and the 3 year return at an 18.8% decline. This may have investors reassessing both its growth potential and its risks. Silgan has recently been in focus around its position in packaging and...

If you are looking at NIQ Global Intelligence and wondering whether the current share price really reflects its underlying value, this article is written to help you answer that question with numbers rather than guesswork. Over the short term, the stock has seen a 4.9% decline over the last 7 days, a 4.8% gain over the last 30 days, and an 8.4% return year to date. These moves can change how the market views both its growth potential and its risks. Recent coverage has focused on NIQ Global...

If you are wondering whether PROG Holdings at around US$32.42 is a bargain or a value trap, you are in the right place to break that question down calmly and clearly. The stock has had a mixed run, with a 7.1% return over the last 30 days and 10.4% year to date, set against a 23.7% decline over the past year and a 33.3% return over three years, while the five year return sits at a 33.6% decline. Recent coverage around PROG Holdings has focused on its position within the diversified...

As the United States stock market experiences fluctuations with major indices like the Dow Jones, S&P 500, and Nasdaq showing mixed performance amidst economic developments and leadership changes at the Federal Reserve, investors are keenly observing opportunities for value investing. In this climate, identifying stocks that are trading below their intrinsic values can present potential opportunities for those looking to capitalize on market inefficiencies.

As the U.S. stock market navigates a complex landscape with major indices like the Dow Jones, S&P 500, and Nasdaq poised for monthly gains despite recent pullbacks, investors are keenly observing changes in leadership at the Federal Reserve and fluctuating commodity prices. In this environment of cautious optimism, growth companies with high insider ownership often stand out as potentially resilient investments due to their alignment of management interests with shareholders and potential for...

As the U.S. stock market navigates through a mix of economic signals, including potential leadership changes at the Federal Reserve and fluctuating commodity prices, investors are evaluating their strategies for both stability and growth. In this context, penny stocks—often smaller or newer companies—remain an intriguing area for those seeking to capitalize on untapped potential. Despite being an older term, these stocks can offer a blend of affordability and growth when supported by solid...

As the U.S. stock market navigates a landscape of fluctuating indices and economic indicators, small-cap stocks have emerged as intriguing opportunities amidst broader market dynamics. With major indices like the S&P 500 showing resilience despite recent pullbacks, investors are increasingly looking toward lesser-known small-cap companies that may offer unique growth potential in this environment. Identifying promising stocks in this segment often involves finding companies with strong...

As the U.S. stock market navigates a period of mixed performance with major indices poised for monthly gains despite recent pullbacks, investors are keenly observing the impact of economic policies and interest rate changes on their portfolios. In this environment, dividend stocks can offer a measure of stability and income potential, making them an attractive option for those looking to balance growth with consistent returns in uncertain times.